Hofseth BioCare ASA (HOFBF)
USD 0.16
(0.0%)
USD 0.16
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -106.68 Million NOK | -663.1% |
| 2022 | -13.98 Million NOK | 2.39% |
| 2021 | -14.32 Million NOK | -20.12% |
| 2020 | -11.92 Million NOK | -17.45% |
| 2019 | -10.15 Million NOK | 88.02% |
| 2018 | -84.76 Million NOK | -414.53% |
| 2017 | -16.47 Million NOK | 88.83% |
| 2016 | -147.45 Million NOK | -47.16% |
| 2015 | -100.19 Million NOK | -49.73% |
| 2014 | -66.91 Million NOK | -28.35% |
| 2013 | -52.13 Million NOK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.64 Million USD | 39.45% |
| 2024 Q1 | -2.68 Million USD | 44.1% |
| 2023 Q3 | -2.12 Million USD | -495.61% |
| 2023 FY | -106.68 Million USD | -663.1% |
| 2023 Q1 | -3.61 Million USD | 6.81% |
| 2023 Q2 | 536.39 Thousand USD | 114.85% |
| 2023 Q4 | -5.09 Million USD | -140.09% |
| 2022 Q3 | -3.22 Million NOK | -12.48% |
| 2022 Q2 | -2.86 Million NOK | 29.29% |
| 2022 FY | -13.98 Million NOK | 2.39% |
| 2022 Q1 | -4.04 Million NOK | -3.25% |
| 2022 Q4 | -3.87 Million NOK | -20.34% |
| 2021 Q4 | -3.92 Million NOK | 9.15% |
| 2021 Q3 | -4.31 Million NOK | -50.76% |
| 2021 FY | -14.32 Million NOK | -20.12% |
| 2021 Q1 | -3.14 Million NOK | 89.88% |
| 2021 Q2 | -2.86 Million NOK | 8.95% |
| 2020 Q4 | -31.06 Million NOK | 5.47% |
| 2020 Q1 | -17.88 Million NOK | 46.51% |
| 2020 FY | -11.92 Million NOK | -17.45% |
| 2020 Q2 | -20.27 Million NOK | -13.36% |
| 2020 Q3 | -32.86 Million NOK | -62.09% |
| 2019 Q4 | -33.43 Million NOK | -83.02% |
| 2019 FY | -10.15 Million NOK | 88.02% |
| 2019 Q3 | -18.26 Million NOK | -8.29% |
| 2019 Q2 | -16.86 Million NOK | 18.26% |
| 2019 Q1 | -20.63 Million NOK | 12.0% |
| 2018 Q3 | -20.32 Million NOK | -7.9% |
| 2018 Q2 | -18.83 Million NOK | 15.01% |
| 2018 Q1 | -22.16 Million NOK | -71.91% |
| 2018 FY | -84.76 Million NOK | -414.53% |
| 2018 Q4 | -23.45 Million NOK | -15.41% |
| 2017 FY | -16.47 Million NOK | 88.83% |
| 2017 Q3 | -12.02 Million NOK | 37.7% |
| 2017 Q1 | 27.75 Million NOK | 212.28% |
| 2017 Q2 | -19.3 Million NOK | -169.57% |
| 2017 Q4 | -12.89 Million NOK | -7.17% |
| 2016 Q4 | -24.71 Million NOK | 43.79% |
| 2016 Q2 | -50.58 Million NOK | -79.48% |
| 2016 Q1 | -28.18 Million NOK | 33.36% |
| 2016 FY | -147.45 Million NOK | -47.16% |
| 2016 Q3 | -43.96 Million NOK | 13.08% |
| 2015 Q4 | -42.29 Million NOK | -159.26% |
| 2015 Q2 | -22.71 Million NOK | -20.33% |
| 2015 Q1 | -18.87 Million NOK | 28.49% |
| 2015 FY | -100.19 Million NOK | -49.73% |
| 2015 Q3 | -16.31 Million NOK | 28.19% |
| 2014 Q1 | -15.96 Million NOK | -86.99% |
| 2014 Q4 | -26.39 Million NOK | -90.88% |
| 2014 Q3 | -13.82 Million NOK | -5.69% |
| 2014 Q2 | -13.08 Million NOK | 18.06% |
| 2014 FY | -66.91 Million NOK | -28.35% |
| 2013 Q4 | -8.54 Million NOK | -0.05% |
| 2013 Q1 | -26.28 Million NOK | 42.06% |
| 2013 Q2 | -17.4 Million NOK | 33.79% |
| 2013 FY | -52.13 Million NOK | 0.0% |
| 2013 Q3 | -8.53 Million NOK | 50.95% |
| 2012 Q3 | -7.1 Million NOK | 27.3% |
| 2012 Q2 | -9.77 Million NOK | 15.72% |
| 2012 Q4 | -45.36 Million NOK | -538.08% |
| 2012 Q1 | -11.6 Million NOK | -82.13% |
| 2011 Q3 | -4.33 Million NOK | -2.38% |
| 2011 Q2 | -4.22 Million NOK | -3.0% |
| 2011 Q1 | -4.1 Million NOK | 27.66% |
| 2011 Q4 | -6.37 Million NOK | -47.12% |
| 2010 Q4 | -5.67 Million NOK | -477.9% |
| 2010 Q3 | -982.3 Thousand NOK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 52.97 Million USD | 301.368% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -1427.789% |
| CSL Limited | 2.64 Billion USD | 104.038% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 263.793% |
| Regen BioPharma, Inc. | 1.02 Million USD | 10523.27% |
| BioStem Technologies, Inc. | -8.48 Million USD | -1157.612% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -2693.48% |
| Qrons Inc. | -789.34 Thousand USD | -13415.349% |
| Nascent Biotech, Inc. | -2.08 Million USD | -5010.117% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | -70.423% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -1249.889% |
| Skye Bioscience, Inc. | -37.64 Million USD | -183.394% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -25577.11% |
| Rebus Holdings, Inc. | -1.02 Million USD | -10359.118% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -572.17% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -7888.657% |
| Genscript Biotech Corporation | -95.47 Million USD | -11.737% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -16769.358% |
| Adynxx, Inc. | - USD | Infinity% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | -42.314% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -1522.281% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -38920.563% |
| SQZ Biotechnologies Company | -79.46 Million USD | -34.253% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -3588.398% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -5760.003% |
| Mesoblast Limited | -87.95 Million USD | -21.291% |
| Marizyme, Inc. | -65.34 Million USD | -63.256% |
| Genus plc | 7.9 Million USD | 1450.418% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -879.485% |
| Pharming Group N.V. | -10.54 Million USD | -911.405% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -4816.689% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -2775.371% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -1106.275% |
| ContraFect Corporation | -65.15 Million USD | -63.742% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -2083.414% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -6075.733% |
| IMV Inc. | -36.48 Million USD | -192.397% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -1223.663% |
| MultiCell Technologies, Inc. | -380.07 USD | -28069203.023% |
| ONE Bio Corp. | 8.67 Million USD | 1329.547% |
| Accustem Sciences Inc. | -3.74 Million USD | -2747.599% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -106.382% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -8319.236% |
| Q BioMed Inc. | -2.05 Million USD | -5098.741% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -2757.836% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -4380.841% |
| Biomind Labs Inc. | -1.21 Million USD | -8685.418% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | -78.623% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -3339.426% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -5373.031% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -712259.776% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -1733.907% |
| GB Sciences, Inc. | -1.36 Million USD | -7734.677% |
| Alpha Cognition Inc. | -13.77 Million USD | -674.605% |
| HST Global, Inc. | -146.21 Thousand USD | -72865.597% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -5979.597% |
| Halberd Corporation | -79.67 Thousand USD | -133796.029% |
| Enzolytics Inc. | -2.17 Million USD | -4800.838% |
| Agentix Corp. | -1.37 Million USD | -7663.218% |
| Resverlogix Corp. | -3.61 Million USD | -2855.208% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -3263.87% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 63.843% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 108960.204% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 1640.639% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -2585.205% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -3425.388% |
| AVAX Technologies, Inc. | -6.41 Million USD | -1563.375% |
| Zenith Capital Corp. | -10.59 Million USD | -906.823% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -458909.552% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -2473.195% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -176408.808% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -5220.543% |
| Kadimastem Ltd | -3.3 Million USD | -3125.587% |
| Helix BioMedix, Inc. | -1.05 Million USD | -10002.012% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -24070.932% |
| LadRx Corporation | 400.44 Thousand USD | 26741.245% |
| Cell Source, Inc. | -5.32 Million USD | -1904.863% |
| Regen BioPharma, Inc. | 1.02 Million USD | 10523.27% |
| NovAccess Global Inc. | -4.76 Million USD | -2136.922% |
| Affymax, Inc. | -14.42 Million USD | -639.621% |
| Itoco Inc. | -1.86 Million USD | -5608.041% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -2301.399% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -6292.031% |
| Mobile Lads Corp. | -2.26 Million USD | -4613.621% |
| CytoDyn Inc. | -49.84 Million USD | -114.047% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -134885.386% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -46664.741% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -11230.825% |
| SYBLEU INC | -180.3 Thousand USD | -59068.404% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -6515.028% |
| International Stem Cell Corporation | -131 Thousand USD | -81337.405% |
| Bioxytran, Inc. | -4.28 Million USD | -2392.592% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -196470.976% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -4116.308% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -121.923% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -4946.5% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -13561.772% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -3267.519% |
| Neutra Corp. | -233.46 Thousand USD | -45595.5% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -425.765% |
| PureTech Health plc | -65.69 Million USD | -62.386% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -401.647% |
| IXICO plc | -1.17 Million USD | -8956.282% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -974.675% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -86.744% |
| CSL Limited | 2.64 Billion USD | 104.038% |
| Cellectis S.A. | -103.17 Million USD | -3.401% |